Giorgos Karakousis Selected Research

Giorgos Karakousis Research Topics

Disease

32	Melanoma (Melanoma, Malignant) 02/2024 - 06/2013
18	Neoplasms (Cancer) 01/2022 - 04/2004
10	Neoplasm Metastasis (Metastasis) 12/2022 - 08/2009
3	Lymphoma (Lymphomas) 10/2018 - 10/2011
3	Sarcoma (Soft Tissue Sarcoma) 12/2015 - 02/2010
2	Glioma (Gliomas) 02/2019 - 04/2018
2	Carcinoma (Carcinomatosis) 01/2019 - 04/2004
2	Circulating Neoplastic Cells 01/2016 - 01/2015
1	Mesothelioma 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Meningioma (Meningiomas) 11/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2019
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 03/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018
1	Astrocytoma (Pilocytic Astrocytoma) 09/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Myocardial Infarction 04/2015
1	Virilism (Virilization) 01/2012
1	Myelolipoma 01/2012
1	Oxyphilic Adenoma (Oncocytoma) 01/2012
1	Hypoxia (Hypoxemia) 02/2010
1	Carcinogenesis 02/2010
1	Ascites 04/2004
1	Ovarian Teratoma 04/2004

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2010
3	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2017
3	VemurafenibIBA 03/2019 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 03/2014
2	Circulating Tumor DNAIBA 01/2016 - 12/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015 - 02/2010
1	AntibodiesIBA 06/2023
1	Interleukin-2 (IL2)IBA 06/2023
1	matrigelIBA 06/2023
1	CollagenIBA 06/2023
1	Capsules (Microcapsules)IBA 05/2021
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	IGF-I-IGFBP-3 complex FDA Link 03/2019
1	Vascular Endothelial Growth Factor CIBA 01/2019
1	Drug CombinationsIBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2018
1	CateninsIBA 04/2016
1	Microphthalmia-Associated Transcription FactorIBA 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	chlorotriphenylsilane (CTPS)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Cytidine Triphosphate (CTP)IBA 01/2016
1	Cadherins (E-Cadherin)IBA 07/2015
1	Mitogen-Activated Protein KinasesIBA 04/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015
1	Complement System Proteins (Complement)IBA 01/2015
1	Endoplasmic Reticulum Chaperone BiPIBA 03/2014
1	AndrogensIBA 01/2012
1	Testosterone (Sustanon)FDA Link 01/2012
1	Inhibins (Inhibin)IBA 01/2012
1	MART-1 AntigenIBA 01/2012
1	Dihydrotachysterol (AT 10)IBA 10/2011
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 02/2010
1	Erythropoietin FDA Link 02/2010
1	Interferon-betaIBA 04/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2004
1	Saline SolutionIBA 04/2004

Therapy/Procedure

20	Therapeutics 11/2023 - 04/2004
8	Immunotherapy 02/2024 - 06/2013
7	Radiotherapy 01/2021 - 10/2011
5	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2022 - 08/2009
2	Neoadjuvant Therapy 01/2023 - 01/2022
2	Chemoradiotherapy 01/2018 - 09/2017
1	Minimally Invasive Surgical Procedures 12/2022
1	Ultrasonic Surgical Procedures 01/2021
1	Adjuvant Radiotherapy 11/2019
1	Cryosurgery 07/2019
1	Mohs Surgery (Mohs' Micrographic Surgery) 01/2019
1	Craniotomy 10/2018
1	Salvage Therapy 01/2018
1	Radiofrequency Ablation 01/2018
1	Adjuvant Chemotherapy 09/2017
1	Subacute Care 01/2017
1	Mechanical Ventilators (Ventilator) 04/2015
1	Aftercare (After-Treatment) 06/2013